Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
RNA sequencing liquid biopsy for cardiovascular and complex disease screening
MultiplAI Health is a Cambridge biotech developing a whole-blood RNA sequencing test for early screening of cardiovascular and other complex diseases. Its platform combines transcriptomic profiling of blood samples with a patented data transformation process and proprietary deep learning algorithms to generate…
Purpose-built technology and life science campus near Cambridge
TTP Campus is a bespoke research and technology campus located in Melbourn, Cambridgeshire, developed and operated by TTP Group. The campus houses TTP plc alongside a growing cluster of spinout companies. Facilities include CL2 wet laboratories, chemistry labs, low-vibration suites for laser and optics work, advanced…
CreaTap antibody engineering for improved solid tumour penetration
Creasallis is a biotechnology company developing antibody engineering technologies intended to improve drug delivery into solid tumours. Its patented CreaTap platform modifies therapeutic antibodies to promote deeper penetration into tumour tissue. The approach is under development for monoclonal antibodies,…
Cambridge innovation centre for science and technology businesses
St John's Innovation Centre is a business incubator supporting science, technology and research-led companies with flexible workspace and business development services. Established by St John's College, University of Cambridge, it opened in 1987 within St John's Innovation Park. The centre accommodates early-stage and…
T cell-engaging multispecific antibody fragments for solid tumours
Crescendo Biologics is a clinical-stage biopharmaceutical company developing multispecific therapeutics based on fully human single-domain antibody fragments engineered for enhanced tumour penetration and selective T cell activation within the tumour microenvironment. Its lead programme is in Phase 1b clinical trials…
Molecular farming platform producing specialty proteins from crop leaves
Kyomei is a biotechnology company developing a molecular farming platform that genetically engineers crop plants to produce high-value specialty proteins in their leaves. The company extracts these proteins from agricultural leaf waste that would otherwise be discarded at harvest. Kyomei's ingredients target food…
Sequencing kits for genome-wide off-target analysis of gene editing
Broken String Biosciences is a genomics company that develops tools for measuring the safety of genome editing. Its platform uses next-generation sequencing to map DNA breaks and editing intermediates across the genome, allowing developers to detect and quantify on-target and off-target edits made by nucleases and…
AAV gene therapy targeting the seizure focus in refractory epilepsy
Focalis Bio is a biotechnology company developing gene therapies for focal refractory epilepsy, a condition in which seizures arise from a specific brain region and do not respond to antiseizure medicines. Its lead programme, EPY201, is an AAV9-based gene therapy delivered locally via catheter directly to the…
Neuroactive therapeutics through genetic engineering of fungi and plants
Empyrean Neuroscience is a biopharma company that uses genetic engineering of fungi and plants to develop small molecule therapeutics for neuropsychiatric and neurologic disorders. Using CRISPR/Cas9 and proprietary transformation technologies, the platform enables precise modulation of neuroactive compound production.…
ML-enabled nanoparticle delivery platform for targeted therapeutics
Vector Bioscience is a University of Cambridge spin-out developing a machine learning-enabled drug delivery platform based on metal-organic framework nanoparticles. The technology provides cargo-agnostic, targeted delivery of oligonucleotides and small molecules with controlled release, initially focused on…
Cloud-based informatics platform for drug discovery data management
Collaborative Drug Discovery (CDD) is a software company providing a cloud-based informatics platform for drug discovery research. Its flagship product enables scientists to register compounds, manage bioassay and chemical data, track inventory and capture experiments through an integrated electronic laboratory…
Preclinical CRO delivering integrated drug discovery and development services
Selvita is a contract research organisation providing integrated drug discovery and development services to pharmaceutical and biotechnology companies. The company supports projects from target validation through preclinical candidate nomination, with expertise in medicinal chemistry, pharmacology, DMPK and protein…
Integrated outsourced drug discovery and development platform
RxCelerate is a contract research organisation providing fully integrated drug discovery and development services to pharmaceutical and biotech companies. Based at Babraham Research Campus, the company offers end-to-end programme delivery spanning computational design, antibody discovery, medicinal chemistry, in vitro…
AI-driven drug discovery targeting necrosis and age-related disease
LinkGevity is a preclinical-stage biotechnology company developing anti-necrotic therapeutics for age-related and degenerative diseases. Founded in 2023 and based at Babraham Research Campus, the company's proprietary Blueprint Theory of Ageing identifies necrosis as a key driver of biological decline, informing its…
Small-molecule anti-biofilm add-on therapy for antibiotic-resistant urinary tract infections
BioTryp Therapeutics is a UK-based drug discovery company developing small-molecule therapies that inhibit bacterial biofilm formation. The company's lead programme is an oral add-on therapy designed to be used alongside existing antibiotics, targeting a bacterial protein conserved across more than 85 species to…
Blood-based circulating tumour DNA tests for cancer
Inivata is a liquid biopsy company developing molecular tests for cancer using circulating tumour DNA from blood samples. Its sequencing-based assays identify tumour-associated genetic changes and have been used to investigate residual disease, recurrence and treatment response. The technology supports molecular…
Rare and serious disease therapeutics with Cambridge R&D hub
Insmed is a US biopharmaceutical company with commercial-stage and late-pipeline products spanning respiratory, inflammatory and rare neurological diseases. Its Cambridge facility at Babraham Research Campus, established through the 2023 acquisition of Adrestia, leads drug discovery using the company's synthetic…
Europe's oldest science park, anchored by Cambridge University
Cambridge Science Park is Europe's first science park, founded by Trinity College, Cambridge in 1970 and spanning 152 acres on the northern edge of the city. Trinity College retains the freehold and continues to invest actively in the estate. The park hosts 170 science and technology companies employing over 7,000…
Antibody-oligonucleotide conjugates for spatial biology and proteomics
AbOliGo is a biotechnology company developing antibody-oligonucleotide conjugates (AOCs) for multiplexed protein analysis, spatial biology and single-cell workflows. Its conjugation platform addresses a critical bottleneck in multiomic research, as fewer than 0.1% of commercially available antibodies are currently…
Human biospecimens and rapid tests for diagnostic applications
SeraDiag is a supplier of human biospecimens and rapid diagnostic tests for laboratory research, in vitro diagnostics and personal health screening. It provides characterised human serum, plasma and residual clinical samples from healthy and disease-state donors for assay development, quality control and…